Roche and Spark Therapeutics announce withdrawal and refiling of premerger notification
Roche and Spark Therapeutics announced that Roche has withdrawn its Premerger Notification in connection with Roche's pending acquisition of Spark pursuant to its tender offer to purchase all of the outstanding shares of common stock of Spark for USD 114.50 per Share. April 26, 2019